Acuity director granted 546 deferred stock units

Acuity, Inc. director Marcia J. Avedon received an equity-based fee grant in the form of deferred restricted stock units (DSUs).

Rhea-AI Filing Summary

Acuity, Inc. director Marcia J. Avedon received an equity-based fee grant in the form of deferred restricted stock units (DSUs). On January 21, 2026, she was granted 546 DSUs at a reference value of $320.59 per unit, which was the average of the high and low trading prices of Acuity’s common stock over the five trading days before the grant date.

The DSUs were issued under Acuity’s Amended and Restated 2012 Omnibus Stock Incentive Compensation Plan as a result of her election to receive a portion of annual director fees in DSUs instead of cash. The DSUs vest in full on the first anniversary of the grant date or, if earlier, on the date of the next annual meeting of stockholders, and are payable after retirement in either a lump sum or five annual installments, on a 1-for-1 basis in common stock.

Insider Trade Summary

Grant/Award: 546 shares

Grant/Award 1 txn

Insider AVEDON MARCIA J

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Deferred Restricted Stock Units	546	$0.00	$0.00

Holdings After Transaction: Deferred Restricted Stock Units — 546 contracts (Direct)

Footnotes (3)

1. F1. 1-for-1
2. F2. Deferred Restricted Stock Units (DSUs) issued pursuant to the Issuer's Amended and Restated 2012 Omnibus Stock Incentive Compensation Plan. The DSUs resulted from the Reporting Person's election to receive a portion of annual director fees in the form of a DSU. The DSUs will vest in full on the first anniversary of the grant date, or, if earlier, the date of the next subsequent annual meeting of the Issuer's stockholders following the grant date. Once vested, DSUs will be payable upon retirement in either lump sum or five annual installments.
3. F3. The number of DSUs received was calculated based on $320.59, which was the average of the high and low sales prices of a share of the Issuer's common stock on the five trading dates immediately preceding the date of grant.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Acuity (AYI) director Marcia J. Avedon report on this Form 4?

She reported receiving 546 deferred restricted stock units (DSUs) of Acuity Inc. on January 21, 2026 as part of her director compensation.

How were the 546 DSUs for Acuity (AYI) director compensation calculated?

The 546 DSUs were calculated using a value of $320.59 per unit, based on the average of the high and low sales prices of Acuity’s common stock over the five trading days immediately before the grant date.

When do Marcia J. Avedon’s Acuity (AYI) DSUs vest?

The DSUs will vest in full on the first anniversary of the January 21, 2026 grant date, or earlier if Acuity holds its next annual stockholder meeting before that anniversary.

How and when are the Acuity (AYI) DSUs payable to the director?

Once vested and upon retirement, the DSUs are payable on a 1-for-1 basis in common stock, either in a lump sum or in five annual installments.

Why did Acuity (AYI) issue DSUs instead of cash fees to the director?

The filing states the DSUs resulted from the director’s election to receive a portion of annual director fees in DSUs under Acuity’s Amended and Restated 2012 Omnibus Stock Incentive Compensation Plan.

Is this Acuity (AYI) Form 4 transaction a purchase or a grant?

The transaction is coded as "A" (acquired) and represents a grant of DSUs as equity-based compensation rather than an open-market stock purchase.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 01/23/2026 - 04:10 PM EST Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

AVEDON MARCIA J

(Last) (First) (Middle)

C/O ACUITY INC.

1170 PEACHTREE STREET, NE, SUITE 1200

(Street)

ATLANTA GA 30309

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
ACUITY INC. (DE) [ AYI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
01/21/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Deferred Restricted Stock Units	(1)	01/21/2026		A		546(2)		01/21/2027(2)	(2)	Common Stock	546	$0(3)	546	D

Explanation of Responses:

1. 1-for-1

2. Deferred Restricted Stock Units (DSUs) issued pursuant to the Issuer's Amended and Restated 2012 Omnibus Stock Incentive Compensation Plan. The DSUs resulted from the Reporting Person's election to receive a portion of annual director fees in the form of a DSU. The DSUs will vest in full on the first anniversary of the grant date, or, if earlier, the date of the next subsequent annual meeting of the Issuer's stockholders following the grant date. Once vested, DSUs will be payable upon retirement in either lump sum or five annual installments.

3. The number of DSUs received was calculated based on $320.59, which was the average of the high and low sales prices of a share of the Issuer's common stock on the five trading dates immediately preceding the date of grant.

Remarks:

	/s/ Chanda Kirchner, Attorney-in-Fact for Marcia J. Avedon	01/23/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.